CIPRIANI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 6.328
EU - Europa 5.279
AS - Asia 1.337
OC - Oceania 14
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 8
Totale 12.988
Nazione #
US - Stati Uniti d'America 6.294
GB - Regno Unito 2.276
CN - Cina 1.163
IT - Italia 628
FR - Francia 567
FI - Finlandia 446
IE - Irlanda 386
DE - Germania 353
SE - Svezia 330
UA - Ucraina 148
VN - Vietnam 71
RU - Federazione Russa 45
TR - Turchia 30
CA - Canada 25
NL - Olanda 25
IL - Israele 17
BE - Belgio 16
RO - Romania 16
JP - Giappone 15
AU - Australia 14
EU - Europa 10
SG - Singapore 10
CH - Svizzera 8
MX - Messico 8
ES - Italia 7
PL - Polonia 5
BR - Brasile 4
EG - Egitto 4
HU - Ungheria 4
IR - Iran 4
SK - Slovacchia (Repubblica Slovacca) 4
AT - Austria 3
AZ - Azerbaigian 3
GR - Grecia 3
KR - Corea 3
SA - Arabia Saudita 3
ZA - Sudafrica 3
BG - Bulgaria 2
CL - Cile 2
HK - Hong Kong 2
ID - Indonesia 2
PH - Filippine 2
PK - Pakistan 2
SC - Seychelles 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IN - India 1
IQ - Iraq 1
KE - Kenya 1
KH - Cambogia 1
LT - Lituania 1
MA - Marocco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 12.988
Città #
Southend 2.105
Jacksonville 1.304
Woodbridge 967
Chandler 844
Ann Arbor 580
Houston 559
Dublin 386
Wilmington 224
Lawrence 217
Princeton 217
Beijing 191
Ashburn 155
Verona 145
Nanjing 129
Jinan 109
New York 108
Shenyang 100
Hebei 73
Milan 73
Dong Ket 56
Sindelfingen 47
Changsha 45
Nanchang 45
Helsinki 44
Tianjin 44
Haikou 40
Ningbo 36
Hangzhou 34
Washington 32
Norwalk 31
Dearborn 30
Redwood City 30
Boardman 29
Rome 29
Taiyuan 29
Zhengzhou 28
Guangzhou 26
Jiaxing 25
Taizhou 24
Lancaster 20
San Francisco 18
Toronto 17
Brussels 14
Fuzhou 14
Bologna 13
Düsseldorf 13
Falls Church 13
Los Angeles 13
Lanzhou 12
London 10
Singapore 10
Fairfield 9
Amsterdam 8
Florence 8
Seattle 8
Timisoara 8
Cagliari 7
Dongguan 7
Mexico City 7
Shanghai 7
Canberra 6
Groningen 6
Isorella 6
Auburn Hills 5
Melbourne 5
Tokyo 5
Trento 5
Zurich 5
Berlin 4
Brampton 4
Bratislava 4
Brescia 4
Frankfurt am Main 4
Manchester 4
Padova 4
Redmond 4
Rochester 4
Saint Petersburg 4
San Diego 4
Stockholm 4
Stuttgart 4
Villafranca Tirrena 4
Yicheng 4
Austin 3
Baku 3
Bergamo 3
Budapest 3
Cairo 3
Cambridge 3
Chicago 3
Clearwater 3
Genoa 3
Leipzig 3
Madrid 3
Naples 3
Nola 3
Nova Milanese 3
Phoenix 3
Pima 3
Putignano 3
Totale 9.580
Nome #
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 302
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 278
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 149
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 121
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 114
Assessing risk of bias in randomized controlled trials 110
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 107
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 106
What is a systematic review? 101
Associazione tra TCA e SSRI nella depressione resistente 98
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 98
What is a run-in phase? 98
Allocation concealment and blinding in clinical trials 92
What is a forest plot? 91
Agomelatine and the brave old world of narrative-based medicine 90
Imputing missing standard deviations in meta-analyses can provide accurate results 89
What is a risk ratio? 89
Are all antidepressants really the same? The case of fluoxetine: a systematic review 86
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 86
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 85
Citalopram versus other anti-depressive agents for depression 85
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios 85
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 83
Seven criteria for improving effectiveness trials in psychiatry 83
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 83
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 82
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 82
Antidepressants and benzodiazepines for panic disorder in adults 82
Forensic database study suggests selective serotonin reuptake inhibitors do not increase the risk of suicide in people taking antidepressants 81
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 81
Antidepressive Monotherapie 80
Sertraline versus other antidepressive agents for depression 80
Randomized trials published in Chinese or Western journals: comparative empirical analysis 80
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 80
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 79
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 79
Citalopram versus other anti-depressive agents for depression 77
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 77
Duloxetine versus other anti-depressive agents for depression 76
Depressive disorders 75
Conventional vs. atypical antipsychotic medications [Letter] 74
Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies 74
Comparative efficacy and acceptability of antimanic drugsin acute mania: a multiple-treatments meta-analysis 74
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 74
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 74
Paroxetine versus other anti-depressive agents for depression 73
Azapirones versus placebo for panic disorder in adults 73
Commentary on: Analysis and reporting of factorial trials: a systematic review (McAlister et al., JAMA) 72
Benzodiazepines and risk of dementia: true association or reverse causation? 72
Implementation of treatment guidelines for specialist mental health care 72
Mirtazapine versus other antidepressive agents for depression 71
Dalle revisioni narrative a quelle sitematiche e alle metanalisi, per un approccio moderno alla valutazione dei trattamenti farmacologici in psichiatria 70
Do selective serotonin reuptake inhibitors cause suicide? Authors' reply to Raven 70
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 70
Risk of suicidal behaviour in adults taking antidepressants 70
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. 70
Fluoxetine versus other types of pharmacotherapy for depression (Protocol for a Cochrane Review) 69
Fluoxetine versus other types of pharmacotherapy for depression (Review) 69
Adherence therapy does not improve quality of life in people with schizophrenia [Comment] 69
What is a clinical trial protocol? 69
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 69
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 69
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy 68
Comparison of systematic and narrative reviews: the example of the atypical antipsychotics 68
Suicide, depression, and antidepressants. Patients and clinicians need to balance benefits and harms 67
"Wish bias" in antidepressant drug trials? 67
What is an intention to treat analysis? 67
Trasformare la pratica clinica in ricerca. Un invito a partecipareallo studio CHAT. 67
Citalopram versus other anti-depressive agents for depression. 67
What is a multiple treatments meta-analysis? 67
Understanding and using systematic literature reviews 67
Implementation of treatment guidelines for specialist mental health care 67
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 67
Outcome reporting bias in clinical trials 66
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (Protocol) 66
Olanzapine in long-term treatment for bipolar disorder. 66
Review: Short-term benefit of escitalopram versus citalopram for depression uncertain, but big difference in French health insurance costs. 66
Inglobare la ricerca nella pratica clinica quotidiana 65
Validity of the impact factor of journals as a measure of randomised controlled trial quality 64
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials 63
Haloperidol alone or in combination for acute mania (Protocol for a Cochrane Review). 63
Why internal and external validity of experimental studies are relevant for clinical practice? 63
Antidepressants for Bipolar Disorder 63
What is an individual patient data meta-analysis? 62
Does the addiction of a second antipsychotic drug improve clozapine treatment? 61
What is a randomised controlled trial? 61
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study. 61
Cognitive improvements with antipsychotics: Real or practice effect? - Commentary 60
Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis 60
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis 60
Explanatory and pragmatic trials 59
Novel melatonin-based treatments for major depression 59
What is a factorial trial? 59
Aripiprazole in addition to clozapine in partially responsive patients with schizophrenia: a critical review of case series 58
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis 58
Fluoxetine versus other types of pharmacotherapy for depression 58
Sertraline versus other antidepressive agents for depression 58
Implementation of treatment guidelines for specialist mental health care 58
Imputing response rates from means and standard deviations in meta-analyses 57
Review: atypical antipsychotics are effective adjuncts for treatment resistant depression but increase discontinuation due to adverse effects 57
Totale 7.957
Categoria #
all - tutte 39.699
article - articoli 37.117
book - libri 184
conference - conferenze 0
curatela - curatele 0
other - altro 1.113
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.285
Totale 79.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 0 15 52
2019/20201.729 273 14 9 185 99 209 258 171 60 203 73 175
2020/20211.552 91 311 45 134 227 193 18 148 127 23 137 98
2021/20221.259 72 283 25 57 42 29 12 91 61 32 140 415
2022/20232.741 254 166 333 432 293 573 33 183 321 31 70 52
2023/20241.030 71 130 111 118 162 189 47 92 19 83 8 0
Totale 13.116